CMAJ • May 10, 2005; 172 (10). doi:10.1503/cmaj.1040834.
© 2005 CMA Media Inc. or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by St-Pierre, A. C.
Right arrow Articles by Lamarche, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by St-Pierre, A. C.
Right arrow Articles by Lamarche, B.
Related Collections
Right arrow Ischemic heart disease
Right arrow Other endocrinology
Right arrow Other nutrition & metabolism
Right arrowRelated Article

Research
Recherche

Insulin resistance syndrome, body mass index and the risk of ischemic heart disease

Annie C. St-Pierre, Bernard Cantin, Pascale Mauriège, Jean Bergeron, Gilles R. Dagenais, Jean-Pierre Després and Benoît Lamarche

From the Institute on Nutraceuticals and Functional Foods (St-Pierre, Lamarche), the Lipid Research Centre, CHUL Research Centre (St-Pierre, Bergeron, Lamarche), the Quebec Heart Institute, Laval Hospital Research Centre (Cantin, Dagenais, Després), and the Department of Social and Preventive Medicine, Laval University (Mauriège), Ste-Foy, Que.

Correspondence to: Dr. Benoît Lamarche, Institute on Nutraceuticals and Functional Foods, Pavillon Paul-Comtois, Laval University, Ste-Foy QC G1K 7P4; fax 418 656-5877; benoit.lamarche{at}inaf.ulaval.ca

Background: Many people who are not obese according to standard height and weight criteria may still display features of insulin resistance syndrome and thus be at high risk of ischemic heart disease. We sought to investigate the effect of cumulative features of insulin resistance syndrome on the risk of ischemic heart disease associated with variations in body mass index (BMI) among men who participated in the Québec Cardiovascular Study.

Methods: A cohort of 1824 nondiabetic men free of ischemic heart disease was evaluated at the 1985 baseline evaluation and followed for a period of 13 years, during which 284 first ischemic heart disease events were recorded. Relative hazards (RHs) of ischemic heart disease in 3 BMI groups (normal weight, overweight and obese) were estimated using Cox proportional hazards regression.

Results: Although obese men (BMI ≥ 30 kg/m2) were the most likely to accumulate features of insulin resistance syndrome, the univariate risk of ischemic heart disease in this group was not significantly increased compared with normal-weight men (BMI < 25 kg/m2) (RH 1.26, 95% confidence interval [CI] 0.88–1.80). However, obese men who accumulated more than 4 features of insulin resistance syndrome were at increased risk of ischemic heart disease (RH 1.81, 95% CI 1.02–3.19) compared with normal-weight men who had fewer than 3 features of the syndrome. Conversely, having more than 4 features of insulin resistance syndrome was associated with a 3-fold increase in the risk of ischemic heart disease among normal-weight men (RH 3.01, 95% CI 1.70–5.32).

Interpretation: Although obesity is an important risk factor for ischemic heart disease, variations in BMI alone poorly reflect the risk of ischemic heart disease associated with features of insulin resistance syndrome.


Related Article

Heart disease risk among metabolically healthy obese men and metabolically unhealthy lean men
Ian Janssen
Can. Med. Assoc. J. 2005 172: 1315-1316. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 J Gerontol A Biol Sci Med SciHome page
S. Stenholm, A. Koster, D. E. Alley, D. K. Houston, A. Kanaya, J. S. Lee, A. B. Newman, S. Satterfield, E. M. Simonsick, M. Visser, et al.
Joint Association of Obesity and Metabolic Syndrome With Incident Mobility Limitation in Older Men and Women--Results From the Health, Aging, and Body Composition Study
J Gerontol A Biol Sci Med Sci, October 12, 2009; (2009) glp150v1.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
R. P. Wildman, P. Muntner, K. Reynolds, A. P. McGinn, S. Rajpathak, J. Wylie-Rosett, and M. R. Sowers
The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering: Prevalence and Correlates of 2 Phenotypes Among the US Population (NHANES 1999-2004)
Arch Intern Med, August 11, 2008; 168(15): 1617 - 1624.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Z. T. Bloomgarden
Diabetes and Obesity: Part 1
Diabetes Care, December 1, 2007; 30(12): 3145 - 3151.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Lorenzo, M. Serrano-Rios, M. T. Martinez-Larrad, C. Gonzalez-Villalpando, J. L. Gonzalez-Sanchez, M. J. Martinez-Calatrava, R. Gabriel, and S. M. Haffner
Is Waist Circumference an Essential Component of the Metabolic Syndrome?
Diabetes Care, August 1, 2007; 30(8): 2141 - 2142.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Lee, S. Ma, D. Heng, C.-E. Tan, S.-K. Chew, K. Hughes, and E-S. Tai
Should Central Obesity Be an Optional or Essential Component of the Metabolic Syndrome?: Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study
Diabetes Care, February 1, 2007; 30(2): 343 - 347.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
I. Janssen
Heart disease risk among metabolically healthy obese men and metabolically unhealthy lean men
Can. Med. Assoc. J., May 10, 2005; 172(10): 1315 - 1316.
[Full Text] [PDF]